1. Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open‐label randomized comparative pilot clinical study. (26th September 2019) Authors: Alex, P.; Williams, S.; Sutton, L.; Yesudas, T.; Sutton, C.; Thomas, S.; Centola, M. Journal: Clinical and experimental dermatology Issue: Volume 45:Number 3(2020) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open‐label randomized comparative pilot clinical study. (1st April 2020) Authors: Alex, P.; Williams, S.; Sutton, L.; Yesudas, T.; Sutton, C.; Thomas, S.; Centola, M. Journal: Clinical and experimental dermatology Issue: Volume 45:Number 3(2020) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗